Henry Fechner

Department of Applied Biochemistry, Institute of Biotechnology, Berlin University of Technology

Affiliated withInstitute of Biotechnology, Berlin University of Technology

Research Area

Biography

Henry Fechner has not added Biography.
If you are Henry Fechner and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 7	2016

Other Publications

Article	Year
Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanism. Circulation\| PubMed ID: 12591759	2003
Molecular genetic and expression analysis of alpha-tocopherol transfer protein mRNA in German shepherd dogs with degenerative myelopathy. Berliner und Munchener tierarztliche Wochenschrift\| PubMed ID: 12592926	2003
Regulation of human factor IX expression using doxycycline-inducible gene expression system. Thrombosis and haemostasis\| PubMed ID: 12958607	2003
Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression. The Journal of investigative dermatology\| PubMed ID: 15654977	2005
Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 15771959	2005
An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy. Journal of molecular medicine (Berlin, Germany)\| PubMed ID: 16437213	2006
Gene therapy for gastric cancer: is it promising? World journal of gastroenterology\| PubMed ID: 16489636	2006
A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication. Journal of biotechnology\| PubMed ID: 17083991	2007
Dimethyl sulfoxide enhances doxycycline-dependent protein expression in Tet-On cells. BioTechniques\| PubMed ID: 17390537	2007
Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma. Experimental dermatology\| PubMed ID: 18095940	2008
Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. European heart journal\| PubMed ID: 18390538	2008
Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy. Journal of molecular medicine (Berlin, Germany)\| PubMed ID: 18548221	2008
Inhibition of picornaviruses by means of RNA interference. Nucleic acids symposium series (2004)\| PubMed ID: 18776254	2008
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation\| PubMed ID: 19237664	2009
Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3. Antiviral research\| PubMed ID: 19591879	2009
Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus. Experimental dermatology\| PubMed ID: 19725869	2010
Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38. International journal of cancer\| PubMed ID: 19739070	2010
Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor. Circulation\| PubMed ID: 19933937	2009
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure. Cardiovascular research\| PubMed ID: 20176815	2010
Rapid construction of adeno-associated virus vectors expressing multiple short hairpin RNAs with high antiviral activity against echovirus 30. Oligonucleotides\| PubMed ID: 20649454	2010
Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions. Antiviral research\| PubMed ID: 20708037	2010
Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand. Human gene therapy\| PubMed ID: 20977303	2011
Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator. Circulation\| PubMed ID: 21135363	2010
Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). Vaccine\| PubMed ID: 21195079	2011
Decreased cardiac SERCA2 expression, SR Ca uptake, and contractile function in hypothyroidism are attenuated in SERCA2 overexpressing transgenic rats. American journal of physiology. Heart and circulatory physiology\| PubMed ID: 21217071	2011
Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions. Virology\| PubMed ID: 21236463	2011
Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line. Journal of virology\| PubMed ID: 21976640	2011
Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. Molecules (Basel, Switzerland)\| PubMed ID: 21989310	2011
Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression. Journal of virology\| PubMed ID: 22357277	2012
Application of Mutated miR-206 Target Sites Enables Skeletal Muscle-specific Silencing of Transgene Expression of Cardiotropic AAV9 Vectors. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 23439498	2013
Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication. Virus research\| PubMed ID: 23770153	2013
A novel method for the quantification of adeno-associated virus vectors for RNA interference applications using quantitative polymerase chain reaction and purified genomic adeno-associated v... Human gene therapy methods\| PubMed ID: 23987130	2013
A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum. PloS one\| PubMed ID: 24670775	2014
Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor. Journal of virology\| PubMed ID: 24741103	2014
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q. Journal of virology\| PubMed ID: 24807719	2014
Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice. The Journal of infectious diseases\| PubMed ID: 25193982	2015
Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy. The Journal of infectious diseases\| PubMed ID: 25805750	2015
Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir. Antiviral research\| PubMed ID: 26026665	2015
Use of a three-dimensional humanized liver model for the study of viral gene vectors. Journal of biotechnology\| PubMed ID: 26356676	2015
Application of modified antisense oligonucleotides and siRNAs as antiviral drugs. Future medicinal chemistry\| PubMed ID: 26381598	2015
The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection. Journal of virology\| PubMed ID: 27030267	2016
Biological antivirals for treatment of adenovirus infections. Antiviral therapy\| PubMed ID: 27032991	2016
MicroRNA-regulated viral vectors for gene therapy. World journal of experimental medicine\| PubMed ID: 27226955	2016